Cancer genomics

Defining FERMT2 as a regulator of tumour cell state plasticity and metastatic stress adaptation in prostate cancer

Queen's University Belfast

School of Medicine, Dentistry and Biomedical Sciences

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

My research focuses on cancer genomics and bioinformatics, investigating how non-coding mutations drive cancer progression. I integrate GWAS, epigenetics, and tumour sequencing to identify regulatory elements influencing disease risk. In colorectal cancer and AML, I study cryptic transcription and translation to understand how tumour-specific antigens arise and are regulated. Functional genomics experiments are used to explore the mechanisms underpinning these processes and their translational potential.

  • Dr Sarah Maguire: School of Medicine, Dentistry and Biomedical Sciences

Contact info

  • View Academic Profile
  • s.maguire@qub.ac.uk
  • 02890972940

Research Interests

Open to PhD applications in the fields of:

Make a PhD enquiry

  • Cancer genomics
  • Bioinformatics
  • Single-cell omics
  • Translational oncology

Current Research Opportunities

  • Defining FERMT2 as a regulator of tumour cell state plasticity and metastatic stress adaptation in prostate cancer

Public outreach & key achievements

  • Academic Lead for Bioinformatics at the Future Medicines Institute and the QUB Genomics and Cytometry Core.
  • Actively engaged in public engagement on cancer genomics, including media appearances and school outreach.

Discover More

  • Faculty of Medicine, Health and Life Sciences
  • School of Medicine, Dentistry and Biomedical Sciences

Research areas

Cancer genomicsBioinformaticsgenomicsOncologyGenomicsCancer

Related PhD opportunities